264 related articles for article (PubMed ID: 29958856)
21. Risk of a post-colonoscopy colorectal cancer diagnosis in patients with inflammatory bowel disease: a population-based cohort study.
Schønfeldt Troelsen F; Sørensen HT; Pedersen L; Erichsen R
Endoscopy; 2021 Oct; 53(10):1023-1033. PubMed ID: 33241540
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with colorectal cancer occurrence after colonoscopy that did not diagnose colorectal cancer.
Cheung D; Evison F; Patel P; Trudgill N
Gastrointest Endosc; 2016 Aug; 84(2):287-295.e1. PubMed ID: 26827612
[TBL] [Abstract][Full Text] [Related]
23. Post-colonoscopy cancer rate at a tertiary referral hospital in Australia: A data linkage analysis.
Lamba M; Khaing MM; Ma X; Ryan K; Appleyard M; Leggett B; Grimpen F
J Gastroenterol Hepatol; 2023 May; 38(5):740-746. PubMed ID: 36436544
[TBL] [Abstract][Full Text] [Related]
24. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
25. Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program.
Bronzwaer MES; Depla ACTM; van Lelyveld N; Spanier BWM; Oosterhout YH; van Leerdam ME; Spaander MCW; Dekker E;
Gastrointest Endosc; 2019 Jan; 89(1):1-13. PubMed ID: 30240879
[TBL] [Abstract][Full Text] [Related]
26. Post-imaging colorectal cancer or interval cancer rates after CT colonography: a systematic review and meta-analysis.
Obaro AE; Plumb AA; Fanshawe TR; Torres US; Baldwin-Cleland R; Taylor SA; Halligan S; Burling DN
Lancet Gastroenterol Hepatol; 2018 May; 3(5):326-336. PubMed ID: 29472116
[TBL] [Abstract][Full Text] [Related]
27. Quality indicators for screening colonoscopy and colonoscopist performance and the subsequent risk of interval colorectal cancer: a systematic review.
Lund M; Trads M; Njor SH; Erichsen R; Andersen B
JBI Database System Rev Implement Rep; 2019 Nov; 17(11):2265-2300. PubMed ID: 31188154
[TBL] [Abstract][Full Text] [Related]
28. Variation in post-colonoscopy colorectal cancer across colonoscopy providers in English National Health Service: population based cohort study.
Burr NE; Derbyshire E; Taylor J; Whalley S; Subramanian V; Finan PJ; Rutter MD; Valori R; Morris EJA
BMJ; 2019 Nov; 367():l6090. PubMed ID: 31722875
[TBL] [Abstract][Full Text] [Related]
29. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM
Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159
[TBL] [Abstract][Full Text] [Related]
30. Clinical and endoscopist factors associated with post-colonoscopy colorectal cancer in a population-based sample.
Dossa F; Sutradhar R; Saskin R; Hsieh E; Henry P; Richardson DP; Leake PA; Forbes SS; Paszat LF; Rabeneck L; Baxter NN
Colorectal Dis; 2021 Mar; 23(3):635-645. PubMed ID: 33058360
[TBL] [Abstract][Full Text] [Related]
31. Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC in the English National Health Service.
Morris EJ; Rutter MD; Finan PJ; Thomas JD; Valori R
Gut; 2015 Aug; 64(8):1248-56. PubMed ID: 25416064
[TBL] [Abstract][Full Text] [Related]
32. Post-colonoscopy colorectal cancers in Sweden: room for quality improvement.
Forsberg A; Hammar U; Ekbom A; Hultcrantz R
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):855-860. PubMed ID: 28410353
[TBL] [Abstract][Full Text] [Related]
33. Validation of post-colonoscopy colorectal cancer (PCCRC) cases reported at national level following local root cause analysis: REFLECT study.
Ahmad A; Dhillon A; Saunders BP; Kabir M; Thomas-Gibson S
Frontline Gastroenterol; 2022; 13(5):374-380. PubMed ID: 36051952
[TBL] [Abstract][Full Text] [Related]
34. Interval colorectal cancer: a challenging field in colorectal cancer.
Dong SH; Huang JQ; Chen JS
Future Oncol; 2018 Jun; 14(13):1307-1316. PubMed ID: 29741114
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology, characteristics, and survival of post-colonoscopy colorectal cancer in Asia: A population-based study.
Cheung KS; Chen L; Seto WK; Leung WK
J Gastroenterol Hepatol; 2019 Sep; 34(9):1545-1553. PubMed ID: 30932240
[TBL] [Abstract][Full Text] [Related]
36. Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.
Leddin D; Lieberman DA; Tse F; Barkun AN; Abou-Setta AM; Marshall JK; Samadder NJ; Singh H; Telford JJ; Tinmouth J; Wilkinson AN; Leontiadis GI
Gastroenterology; 2018 Nov; 155(5):1325-1347.e3. PubMed ID: 30121253
[TBL] [Abstract][Full Text] [Related]
37. Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival.
Kang JH; Jensen CD; Merchant SA; Lee JK
Clin Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38782174
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Post-Colonoscopy Colorectal Cancer and Its Subtypes in a Screening Programme.
Unanue-Arza S; Idigoras-Rubio I; Fernández-Landa MJ; Bilbao-Iturribarria I; Bujanda L; Portillo I
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680254
[TBL] [Abstract][Full Text] [Related]
39. Post-colonoscopy colorectal cancer rate in the era of high-definition colonoscopy.
Iwatate M; Kitagawa T; Katayama Y; Tokutomi N; Ban S; Hattori S; Hasuike N; Sano W; Sano Y; Tamano M
World J Gastroenterol; 2017 Nov; 23(42):7609-7617. PubMed ID: 29204060
[TBL] [Abstract][Full Text] [Related]
40. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening.
Sung JJ; Ng SC; Chan FK; Chiu HM; Kim HS; Matsuda T; Ng SS; Lau JY; Zheng S; Adler S; Reddy N; Yeoh KG; Tsoi KK; Ching JY; Kuipers EJ; Rabeneck L; Young GP; Steele RJ; Lieberman D; Goh KL;
Gut; 2015 Jan; 64(1):121-32. PubMed ID: 24647008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
